BGLC logo

BioNexus Gene Lab (BGLC)

Profile

Full Name

BioNexus Gene Lab Corp.

Ticker Symbol

BGLC

Exchange

NASDAQ

Sector

Basic Materials

Industry

Specialty Chemicals

Country

Malaysia

IPO

January 8, 2021

Indexes

Not included

Website

http://www.bionexusgenelab.com

Employees

30

Key Details

Price

$2.63(+21.20%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$9.77M(-10.60% YoY)

Annual EPS

-$1.83(-297.83% YoY)

PE ratio

-

Next earnings date

May 15, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$2.63
BGLC price is $2.63

30-Day Relative Volume

24.32
BGLC 30-day relative volume is 24.32

Price Performance

Price Most recent change

+21.2%
BGLC price was up +21.2% on Apr 11, 2025

Price YTD change

-6.07%
BGLC price is down -6.07% since January 1st

Price 1-year change

-60.69%
BGLC price is down -60.69% year-on-year

Price 3-year change

-98.69%
BGLC price is down -98.69% over the past 3 years

Price Range

Price All-time high

$285.60
BGLC price is currently -99.08% below its historical high of $285.60

Price 3-year low

$0.08
BGLC price is currently +3187.50% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$4.73M
BGLC market capitalization is $4.73 million

Market cap 3-year change

-98.35%
BGLC market capitalization is down -98.35% over the past 3 years

Market cap All-time high

$407.49M
BGLC market capitalization is currently -98.84% below its historical high of $407.49 million

Market cap sector rank

4.12%
BGLC market capitalization is higher than 4.12% of companies in Basic Materials sector

Shares Outstanding

Shares Outstanding 1-Year Change

+1.7%
BGLC shares outstanding is up +1.7% year-on-year

Shares Outstanding 3-Year Change

+25.93%
BGLC shares outstanding is up +25.93% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

-0.12
BGLC beta is -0.12

200-day SMA

$3.74
BGLC price is currently -29.61% below its 200-day simple moving average

50-day SMA

$3.27
BGLC price is currently -19.63% below its 50-day simple moving average

RSI

46.38
BGLC 14-day relative strength index is 46.38

Volume

24.32
BGLC 30-day relative volume is 24.32

ATR

$1.28
BGLC average true range is $1.28

10-day Historical Volatility

241.95%
BGLC 10-day historical volatility is 241.95%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$9.77M
BGLC annual revenue is $9.77 million

Revenue Analysts estimate

-
BGLC annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-10.6%
BGLC annual revenue is down -10.6% year-on-year

Revenue Sector rank

8.37%
BGLC annual revenue is higher than 8.37% of companies in Basic Materials sector

EPS

EPS

-$1.83
BGLC annual earnings per share is -$1.83

EPS Analysts estimate

-
BGLC annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

-297.83%
BGLC annual earnings per share is down -297.83% year-on-year

EPS Sector rank

10.82%
BGLC annual earnings per share is higher than 10.82% of companies in Basic Materials sector

Profit

Gross profit

$1.33M
BGLC annual gross profit is $1.33 million

Gross margin

13.61%
BGLC annual gross profit margin is 13.61%

Operating profit

-$2.59M
BGLC annual operating income is -$2.59 million

Operating margin

-26.54%
BGLC annual operating profit margin is -26.54%

Net income

-$2.63M
BGLC annual net profit is -$2.63 million

Net margin

-26.91%
BGLC annual net profit margin is -26.91%

Expenses

Total expenses

$12.36M
BGLC annual total expenses is $12.36 million

Operating expenses

$3.92M
BGLC annual total operating expenses is $3.92 million

Cost of goods sold

$8.44M
BGLC annual cost of goods sold is $8.44 million

Selling, general & administrative expenses

$4.41M
BGLC annual SGA is $4.41 million

Depreciation and amortization

$108.40K
BGLC annual depreciation & amortization is $108.40 thousand

Interest expense

$13.90K
BGLC annual interest expense is $13.90 thousand

Income tax

$21.50K
BGLC annual income tax is $21.50 thousand

EBIT & EBITDA

EBIT

-$2.59M
BGLC annual earnings before interest & taxes is -$2.59 million

EBITDA

-$2.49M
BGLC annual EBITDA is -$2.49 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$11.40M
BGLC annual total assets is $11.40 million

Non current assets

$3.35M
BGLC annual long term assets is $3.35 million

Current assets

$8.05M
BGLC annual total current assets is $8.05 million

Cash and cash equivalents

$5.93M
BGLC annual cash & cash equivalents is $5.93 million

Accounts receivable

$799.70K
BGLC annual accounts receivable is $799.70 thousand

Inventory

$1.14M
BGLC annual inventory is $1.14 million

Liabilities

Total liabilities

$1.74M
BGLC annual total liabilities is $1.74 million

Long term liabilities

$111.00K
BGLC annual total long term liabilities is $111.00 thousand

Current liabilities

$1.63M
BGLC annual total current liabilities is $1.63 million

Accounts payable

$1.40M
BGLC annual accounts payable is $1.40 million

Debt

Total debt

$133.40K
BGLC annual total debt is $133.40 thousand

Total debt 1-year change

+134.86%
BGLC annual total debt is up +134.86% year-on-year

Long term debt

$98.80K
BGLC annual long term debt is $98.80 thousand

Short term debt

$34.60K
BGLC annual short term debt is $34.60 thousand

Equity & Capital

Shareholders equity

$9.66M
BGLC annual stockholders equity is $9.66 million

Book value

$9.66M
BGLC annual book value is $9.66 million

Retained earnings

-$1.84M
BGLC annual retained earnings is -$1.84 million

Working capital

$6.42M
BGLC annual working capital is $6.42 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$1.30M
BGLC annual cash flow from operations is -$1.30 million

Cash from operations 1-year change

-335.88%
BGLC annual cash flow from operations is down -335.88% year-on-year

Cash from investing

-$382.60K
BGLC annual cash flow from investing activities is -$382.60 thousand

Cash from investing 1-year change

+15.07%
BGLC annual cash flow from investing activities is up +15.07% year-on-year

Cash from financing

$5.75M
BGLC annual cash flow from financing activities is $5.75 million

Cash from financing 1-year change

+5218.21%
BGLC annual cash flow from financing activities is up +5218.21% year-on-year

CAPEX

CAPEX

$149.40K
BGLC annual capital expenditures is $149.40 thousand

CAPEX 1-year change

+175.65%
BGLC annual capital expenditures is up +175.65% year-on-year

Free Cash Flow

Free cash flow

-$1.45M
BGLC annual free cash flow is -$1.45 million

Free cash flow 1-year change

-391.54%
BGLC annual free cash flow is down -391.54% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

13.61%
BGLC annual gross profit margin is 13.61%

Operating margin

-26.54%
BGLC annual operating profit margin is -26.54%

Net margin

-26.91%
BGLC annual net profit margin is -26.91%

ROA & ROE

ROA

-26.11%
BGLC annual return on assets is -26.11%

ROE

-32.21%
BGLC annual return on equity is -32.21%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
BGLC price to earnings ratio value is unknown

PE ratio Sector rank

-
BGLC price to earnings ratio is unknown

PB Ratio

PB ratio

0.50
BGLC price to book ratio is 0.50

PB ratio Sector rank

17.67%
BGLC price to book ratio is higher than 17.67% of companies in Basic Materials sector

PS Ratio

PS ratio

0.51
BGLC price to sales ratio is 0.51

PS ratio Sector rank

25.74%
BGLC price to sales ratio is higher than 25.74% of companies in Basic Materials sector

Enterprise value

Enterprise value

$814.98K
BGLC enterprise value is $814.98 thousand

Enterprise value Sector rank

0.38%
BGLC enterprise value is higher than 0.38% of companies in Basic Materials sector

EV/EBITDA

EV/EBITDA

-1.07
BGLC EV/EBITDA is -1.07

EV/EBITDA Sector rank

27.27%
BGLC EV/EBITDA is higher than 27.27% of companies in Basic Materials sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

4.93
BGLC annual current ratio is 4.93

Quick ratio

4.24
BGLC annual quick ratio is 4.24

Leverage

Debt to equity

0.00
BGLC annual debt to equity ratio is 0.00

Interest coverage ratio

-186.59
BGLC annual interest coverage ratio is -186.59

Risk & Stability

Piotroski F-Score

0
BGLC piotroski f-score is 0

Altman Z-Score

2.18
BGLC altman z-score is 2.18

Analyst ratings

Recent major analysts updates

No data about analysts updates

Institutional Ownership

Similar stocks

ZKIN logo
ZK International Group Co (ZKIN)
NITO logo
N2OFF (NITO)
CRKN logo
Crown ElectroKinetics (CRKN)
SNES logo
SenesTech (SNES)
AUMN logo
Golden Minerals (AUMN)
ITP logo
IT Tech Packaging (ITP)
RETO logo
ReTo Eco-Solutions (RETO)
FMST logo
Foremost Lithium Resource & Technology (FMST)
HGAS logo
Global Gas (HGAS)
  • What is the ticker symbol for BioNexus Gene Lab?
  • Does BioNexus Gene Lab pay dividends?
  • What sector is BioNexus Gene Lab in?
  • What industry is BioNexus Gene Lab in?
  • What country is BioNexus Gene Lab based in?
  • When did BioNexus Gene Lab go public?
  • Is BioNexus Gene Lab in the S&P 500?
  • Is BioNexus Gene Lab in the NASDAQ 100?
  • Is BioNexus Gene Lab in the Dow Jones?
  • When was BioNexus Gene Lab's last earnings report?
  • When does BioNexus Gene Lab report earnings?

What is the ticker symbol for BioNexus Gene Lab?

The ticker symbol for BioNexus Gene Lab is NASDAQ:BGLC

Does BioNexus Gene Lab pay dividends?

No, BioNexus Gene Lab does not pay dividends

What sector is BioNexus Gene Lab in?

BioNexus Gene Lab is in the Basic Materials sector

What industry is BioNexus Gene Lab in?

BioNexus Gene Lab is in the Specialty Chemicals industry

What country is BioNexus Gene Lab based in?

BioNexus Gene Lab is headquartered in Malaysia

When did BioNexus Gene Lab go public?

BioNexus Gene Lab's initial public offering (IPO) was on January 8, 2021

Is BioNexus Gene Lab in the S&P 500?

No, BioNexus Gene Lab is not included in the S&P 500 index

Is BioNexus Gene Lab in the NASDAQ 100?

No, BioNexus Gene Lab is not included in the NASDAQ 100 index

Is BioNexus Gene Lab in the Dow Jones?

No, BioNexus Gene Lab is not included in the Dow Jones index

When was BioNexus Gene Lab's last earnings report?

BioNexus Gene Lab's most recent earnings report was on Nov 15, 2024

When does BioNexus Gene Lab report earnings?

The next expected earnings date for BioNexus Gene Lab is May 15, 2025
On this page